DOSSIER · 13F Holders · Q2 2026
698
ACHILLES THERAPEUTICS PL-ADR
3 institutions still hold ACHILLES THERAPEUTICS PL-ADR as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 00449L102·3 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
3 institutions reported 698 in Q2 2026. Trium Capital LLP leads at 92.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.